Skip to content

Clinical trials

Observational Neuroblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Observational Country / region: United States Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20062
20074
20087
20094
20104
20114
20122
20132
20141
20163
20172
20181
20211
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting9
Terminated8
Active, not recruiting4
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group10
National Cancer Institute (NCI)5
Memorial Sloan Kettering Cancer Center4
St. Jude Children's Research Hospital4
Vanderbilt-Ingram Cancer Center4
Dana-Farber Cancer Institute2
Mayo Clinic2
New Approaches to Neuroblastoma Therapy Consortium2
Children's Hospitals and Clinics of Minnesota1
City of Hope Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma45
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Breast Neoplasms9
Hodgkin Disease9
Neoplasms9
Burkitt Lymphoma8
Leukemia8
Leukemia, Myeloid, Acute8
Lymphoma8
Lymphoma, Non-Hodgkin8

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.